The binding affinity of an antibody is one of the key parameters to determine the efficacy and dosage of an antibody drug. Currently, the methods for improving the binding affinity of antibodies mainly focus on site-mutation, CDR rearrangement, DNA recombinant, etc. With our unique and effective affinity maturation technology, we can quickly spot the key amino acid site in antibody domain. This, in turn, increases the binding affinity of the antibody, reaching at least nM level.

• Effective random mutation through DNA-shuffling
• Mature phage display platform assuring high-quality affinity maturation services
• Precise affinity evaluation
• Competitive pricing